Huuuge Inc.

Transaction in Own Shares • Apr 14, 2022

RB 14/2022

14-04-2022

Purchase of own shares under the buy-back program

Huuuge, Inc. ("Issuer"), announces that as part of the realization ofthe share buyback program (RB 4/2022 and RB 9/2022) the Issuer haspurchased its own shares (ISIN code: US44853H1086), as follows:

- on April 11th, 2022 - 56,899 shares of the total value of PLN984,672.52 , for the average unit price of 17.31 PLN, constituting intotal 0.07% share in the share capital and representing 0.07% in of thetotal number of shares entitled to vote at the stockholder's meeting,

- on April 12th, 2022 - 64,214 shares of the total value of PLN1,107,013.08 for the average unit price of 17.24 PLN, constituting intotal 0.08% share in the share capital and representing 0.08% in thetotal number of shares entitled to vote at the stockholder's meeting,

- on April 13th, 2022 - 65,444 shares of the total value of PLN1,120,591.64, for the average unit price of 17.12 PLN, constituting intotal 0.08% share in the share capital and representing 0.08% in of thetotal number of shares entitled to vote at the stockholder's meeting, and

- on April 14th, 2022 - 62,532 shares of the total value of PLN1,072,571.54, for the average unit price of PLN 17.15, constituting intotal 0.07% share in the share capital and representing 0.07% in thetotal number of shares entitled to vote at the stockholder's meeting.

The transactions were executed through Ipopema Securities S.A.

Including all transactions above the Issuer holds 2,012,533 own shares,constituting 2.39% share in the share capital and representing 2.39% inthe total number of shares entitled to vote at the stockholder's meeting(including treasury shares acquired earlier).

Legal basis: Article 2 Section 2 and 3 of Commission DelegatedRegulation (EU) 2016/1052 of 8 March 2016 supplementing Regulation (EU)No 596/2014 of the European Parliament and of the Council with regard toregulatory technical standards for the conditions applicable to buy-backprogrammes and stabilisation measures in accordance with Article 5Section 3 of the MAR.